Gene Symbol | Gene ID | Gene Info |
---|---|---|
Isl1
|
ENSMUSG00000042258.7 | Isl1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
Isl1 | chr13_116301943_116302222 | 1269 | 0.521660 | 0.42 | 7.6e-04 | Click! |
Isl1 | chr13_116297042_116298232 | 5714 | 0.251573 | -0.39 | 2.0e-03 | Click! |
Isl1 | chr13_116302578_116304501 | 188 | 0.957732 | 0.39 | 2.1e-03 | Click! |
Isl1 | chr13_116305710_116306629 | 228 | 0.945614 | 0.38 | 2.7e-03 | Click! |
Isl1 | chr13_116313112_116313438 | 3586 | 0.267901 | 0.37 | 4.1e-03 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chrX_143930842_143933141 | 15.16 |
Dcx |
doublecortin |
1059 |
0.64 |
chr8_109248831_109249717 | 13.02 |
D030068K23Rik |
RIKEN cDNA D030068K23 gene |
592 |
0.83 |
chr8_45507516_45508498 | 12.46 |
Sorbs2 |
sorbin and SH3 domain containing 2 |
89 |
0.97 |
chr13_44841032_44841435 | 9.80 |
Jarid2 |
jumonji, AT rich interactive domain 2 |
450 |
0.83 |
chr13_8205494_8206737 | 9.76 |
Adarb2 |
adenosine deaminase, RNA-specific, B2 |
3193 |
0.23 |
chr3_127224567_127225242 | 9.16 |
Ank2 |
ankyrin 2, brain |
943 |
0.48 |
chr1_6734529_6735444 | 9.04 |
St18 |
suppression of tumorigenicity 18 |
116 |
0.98 |
chr8_33747278_33748028 | 9.01 |
Smim18 |
small integral membrane protein 18 |
117 |
0.95 |
chr2_6883618_6884699 | 9.00 |
Gm13389 |
predicted gene 13389 |
112 |
0.85 |
chr16_16558986_16560577 | 8.75 |
Fgd4 |
FYVE, RhoGEF and PH domain containing 4 |
209 |
0.94 |
chr8_55939901_55941088 | 8.45 |
Glra3 |
glycine receptor, alpha 3 subunit |
15 |
0.98 |
chr8_70119024_70120981 | 8.44 |
Ncan |
neurocan |
871 |
0.35 |
chr13_44946033_44946635 | 8.28 |
Dtnbp1 |
dystrobrevin binding protein 1 |
810 |
0.7 |
chr3_107041271_107042100 | 8.11 |
AI504432 |
expressed sequence AI504432 |
2181 |
0.26 |
chr11_41999400_42000640 | 8.04 |
Gabrg2 |
gamma-aminobutyric acid (GABA) A receptor, subunit gamma 2 |
336 |
0.92 |
chr7_79505833_79506958 | 7.96 |
Mir9-3 |
microRNA 9-3 |
1131 |
0.28 |
chr4_109343931_109344459 | 7.95 |
Eps15 |
epidermal growth factor receptor pathway substrate 15 |
942 |
0.57 |
chr12_98573315_98573466 | 7.91 |
Kcnk10 |
potassium channel, subfamily K, member 10 |
1322 |
0.36 |
chr10_101681584_101682324 | 7.76 |
Mgat4c |
MGAT4 family, member C |
208 |
0.96 |
chr1_81077232_81078427 | 7.66 |
Nyap2 |
neuronal tyrosine-phophorylated phosphoinositide 3-kinase adaptor 2 |
246 |
0.96 |
chr2_181766837_181767244 | 7.63 |
Myt1 |
myelin transcription factor 1 |
2 |
0.97 |
chr8_109247005_109247806 | 7.32 |
D030068K23Rik |
RIKEN cDNA D030068K23 gene |
2461 |
0.39 |
chr4_134470669_134471383 | 7.31 |
Stmn1 |
stathmin 1 |
1284 |
0.28 |
chr5_131532921_131534054 | 7.17 |
Auts2 |
autism susceptibility candidate 2 |
910 |
0.58 |
chr3_88206822_88208169 | 7.15 |
Gm3764 |
predicted gene 3764 |
183 |
0.86 |
chr8_109245493_109246323 | 7.12 |
D030068K23Rik |
RIKEN cDNA D030068K23 gene |
3958 |
0.33 |
chr11_34315414_34316667 | 7.11 |
Insyn2b |
inhibitory synaptic factor family member 2B |
1218 |
0.45 |
chr6_137253502_137253687 | 7.07 |
Ptpro |
protein tyrosine phosphatase, receptor type, O |
1129 |
0.6 |
chr12_29529828_29531185 | 6.97 |
Gm20208 |
predicted gene, 20208 |
609 |
0.74 |
chr10_49786487_49786915 | 6.92 |
Grik2 |
glutamate receptor, ionotropic, kainate 2 (beta 2) |
2053 |
0.25 |
chr17_90452047_90452824 | 6.78 |
Nrxn1 |
neurexin I |
2387 |
0.31 |
chr15_95525022_95525792 | 6.75 |
Nell2 |
NEL-like 2 |
2771 |
0.35 |
chr13_99446279_99447668 | 6.72 |
Map1b |
microtubule-associated protein 1B |
647 |
0.72 |
chr8_54957303_54957776 | 6.71 |
Gm45263 |
predicted gene 45263 |
2280 |
0.24 |
chr2_25264308_25268001 | 6.59 |
Tprn |
taperin |
1410 |
0.14 |
chr1_50925047_50926055 | 6.56 |
Tmeff2 |
transmembrane protein with EGF-like and two follistatin-like domains 2 |
1968 |
0.38 |
chr8_94994139_94995207 | 6.44 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
77 |
0.95 |
chr15_98983254_98984205 | 6.32 |
4930578M01Rik |
RIKEN cDNA 4930578M01 gene |
102 |
0.93 |
chr8_31089411_31091663 | 6.31 |
Dusp26 |
dual specificity phosphatase 26 (putative) |
733 |
0.65 |
chr16_77598670_77599917 | 6.26 |
Mir99a |
microRNA 99a |
357 |
0.44 |
chr16_77594640_77595970 | 6.26 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
403 |
0.71 |
chr9_40270731_40270960 | 6.23 |
Scn3b |
sodium channel, voltage-gated, type III, beta |
1158 |
0.38 |
chr4_150284018_150284403 | 6.19 |
Rere |
arginine glutamic acid dipeptide (RE) repeats |
2398 |
0.24 |
chr3_45384939_45386122 | 6.04 |
Pcdh10 |
protocadherin 10 |
2897 |
0.22 |
chr1_42700192_42700666 | 6.03 |
Pou3f3 |
POU domain, class 3, transcription factor 3 |
4661 |
0.15 |
chr13_83726534_83727321 | 6.01 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
1179 |
0.35 |
chr2_65566848_65567533 | 5.91 |
Scn3a |
sodium channel, voltage-gated, type III, alpha |
302 |
0.92 |
chr11_46309925_46310526 | 5.75 |
Cyfip2 |
cytoplasmic FMR1 interacting protein 2 |
1995 |
0.28 |
chr16_63862649_63862946 | 5.71 |
Epha3 |
Eph receptor A3 |
616 |
0.83 |
chr18_69597107_69597709 | 5.66 |
Tcf4 |
transcription factor 4 |
2128 |
0.42 |
chr13_83723698_83723849 | 5.59 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
2392 |
0.2 |
chr18_34249368_34249586 | 5.55 |
Apc |
APC, WNT signaling pathway regulator |
1779 |
0.35 |
chr7_82871690_82872524 | 5.55 |
Mex3b |
mex3 RNA binding family member B |
4774 |
0.17 |
chr8_41052368_41053980 | 5.54 |
Gm16193 |
predicted gene 16193 |
64 |
0.96 |
chr1_42699114_42699733 | 5.53 |
Pou3f3 |
POU domain, class 3, transcription factor 3 |
3655 |
0.16 |
chr9_52148115_52149635 | 5.50 |
Zc3h12c |
zinc finger CCCH type containing 12C |
19236 |
0.18 |
chr7_97842700_97844158 | 5.48 |
Pak1 |
p21 (RAC1) activated kinase 1 |
494 |
0.83 |
chr7_51629095_51630495 | 5.47 |
Slc17a6 |
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6 |
315 |
0.88 |
chr12_52700044_52701597 | 5.46 |
Akap6 |
A kinase (PRKA) anchor protein 6 |
1437 |
0.46 |
chr19_47017426_47018238 | 5.46 |
Nt5c2 |
5'-nucleotidase, cytosolic II |
2679 |
0.17 |
chr7_140080531_140082545 | 5.46 |
Caly |
calcyon neuron-specific vesicular protein |
689 |
0.48 |
chr5_116589538_116590511 | 5.45 |
Srrm4 |
serine/arginine repetitive matrix 4 |
1793 |
0.34 |
chr5_37244380_37244680 | 5.43 |
Crmp1 |
collapsin response mediator protein 1 |
1234 |
0.48 |
chr9_43069102_43069597 | 5.42 |
Arhgef12 |
Rho guanine nucleotide exchange factor (GEF) 12 |
26717 |
0.17 |
chrX_84076569_84077653 | 5.39 |
Dmd |
dystrophin, muscular dystrophy |
462 |
0.87 |
chrX_23283125_23283785 | 5.39 |
Klhl13 |
kelch-like 13 |
1374 |
0.57 |
chr9_112232861_112233588 | 5.30 |
Arpp21 |
cyclic AMP-regulated phosphoprotein, 21 |
402 |
0.75 |
chr4_126465012_126466992 | 5.27 |
Ago1 |
argonaute RISC catalytic subunit 1 |
2419 |
0.18 |
chr1_121087490_121087889 | 5.25 |
Celrr |
cerebellum expressed regulatory RNA |
160 |
0.97 |
chr5_88583963_88584847 | 5.19 |
Rufy3 |
RUN and FYVE domain containing 3 |
611 |
0.7 |
chr4_13746200_13747057 | 5.15 |
Runx1t1 |
RUNX1 translocation partner 1 |
3192 |
0.37 |
chr4_17856811_17857094 | 5.14 |
Mmp16 |
matrix metallopeptidase 16 |
3359 |
0.38 |
chr5_35454181_35454829 | 5.11 |
Gm43377 |
predicted gene 43377 |
58407 |
0.08 |
chr4_6986587_6987701 | 5.10 |
Tox |
thymocyte selection-associated high mobility group box |
3339 |
0.35 |
chr19_50676799_50677457 | 5.10 |
Gm26629 |
predicted gene, 26629 |
278 |
0.88 |
chr16_41534559_41535426 | 5.09 |
Lsamp |
limbic system-associated membrane protein |
1573 |
0.55 |
chr12_117692658_117693268 | 5.07 |
Rapgef5 |
Rap guanine nucleotide exchange factor (GEF) 5 |
4007 |
0.27 |
chr13_83722679_83723219 | 5.04 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
1568 |
0.29 |
chr12_3370750_3371679 | 4.97 |
Gm48511 |
predicted gene, 48511 |
2785 |
0.18 |
chr1_25832036_25832712 | 4.94 |
Gm9884 |
predicted gene 9884 |
1717 |
0.22 |
chr13_34125172_34126139 | 4.94 |
Tubb2b |
tubulin, beta 2B class IIB |
4699 |
0.12 |
chr15_88977708_88978900 | 4.93 |
Mlc1 |
megalencephalic leukoencephalopathy with subcortical cysts 1 homolog (human) |
703 |
0.51 |
chr13_83728524_83729044 | 4.92 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
678 |
0.43 |
chr5_43236846_43237650 | 4.90 |
Cpeb2 |
cytoplasmic polyadenylation element binding protein 2 |
67 |
0.96 |
chr4_110290101_110291006 | 4.88 |
Elavl4 |
ELAV like RNA binding protein 4 |
281 |
0.95 |
chrX_153501207_153502250 | 4.87 |
Ubqln2 |
ubiquilin 2 |
3501 |
0.22 |
chr3_68573207_68574269 | 4.84 |
Schip1 |
schwannomin interacting protein 1 |
1493 |
0.45 |
chr5_128430660_128431199 | 4.83 |
Tmem132d |
transmembrane protein 132D |
2148 |
0.27 |
chr3_8509825_8511666 | 4.81 |
Stmn2 |
stathmin-like 2 |
1159 |
0.54 |
chr19_22447648_22448999 | 4.79 |
Trpm3 |
transient receptor potential cation channel, subfamily M, member 3 |
91 |
0.63 |
chr10_92162169_92163486 | 4.79 |
Rmst |
rhabdomyosarcoma 2 associated transcript (non-coding RNA) |
66 |
0.98 |
chr5_120433178_120434996 | 4.79 |
Gm27199 |
predicted gene 27199 |
2320 |
0.19 |
chr4_49842278_49843034 | 4.78 |
Grin3a |
glutamate receptor ionotropic, NMDA3A |
2893 |
0.36 |
chr3_5222045_5223052 | 4.77 |
Zfhx4 |
zinc finger homeodomain 4 |
1043 |
0.46 |
chr12_107996863_107997549 | 4.77 |
Bcl11b |
B cell leukemia/lymphoma 11B |
6208 |
0.3 |
chr13_83715222_83716973 | 4.76 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
5284 |
0.15 |
chr1_168163488_168164140 | 4.74 |
Pbx1 |
pre B cell leukemia homeobox 1 |
848 |
0.75 |
chr2_66633862_66635239 | 4.73 |
Scn9a |
sodium channel, voltage-gated, type IX, alpha |
103 |
0.98 |
chr14_60381648_60381975 | 4.72 |
Amer2 |
APC membrane recruitment 2 |
3525 |
0.27 |
chr12_41483283_41485192 | 4.69 |
Lrrn3 |
leucine rich repeat protein 3, neuronal |
2194 |
0.36 |
chr8_54956899_54957247 | 4.69 |
Gpm6a |
glycoprotein m6a |
2230 |
0.24 |
chr10_90576163_90577493 | 4.69 |
Anks1b |
ankyrin repeat and sterile alpha motif domain containing 1B |
13 |
0.99 |
chr14_60380755_60381381 | 4.67 |
Amer2 |
APC membrane recruitment 2 |
2782 |
0.3 |
chr1_25228097_25229399 | 4.67 |
Adgrb3 |
adhesion G protein-coupled receptor B3 |
78 |
0.96 |
chr6_80020534_80021026 | 4.66 |
Lrrtm4 |
leucine rich repeat transmembrane neuronal 4 |
1137 |
0.48 |
chr4_97582473_97584218 | 4.65 |
E130114P18Rik |
RIKEN cDNA E130114P18 gene |
1251 |
0.53 |
chr5_9723538_9723989 | 4.64 |
Grm3 |
glutamate receptor, metabotropic 3 |
1407 |
0.48 |
chr16_77537075_77537402 | 4.63 |
Gm36963 |
predicted gene, 36963 |
2644 |
0.18 |
chr4_72195085_72196381 | 4.62 |
Tle1 |
transducin-like enhancer of split 1 |
3359 |
0.26 |
chr1_143642293_143642622 | 4.62 |
Cdc73 |
cell division cycle 73, Paf1/RNA polymerase II complex component |
68 |
0.97 |
chr9_101690371_101690976 | 4.61 |
Gm47932 |
predicted gene, 47932 |
67032 |
0.1 |
chr11_77486623_77487566 | 4.61 |
Ankrd13b |
ankyrin repeat domain 13b |
2572 |
0.17 |
chr14_108909489_108909909 | 4.61 |
Slitrk1 |
SLIT and NTRK-like family, member 1 |
4459 |
0.37 |
chr1_184997307_184998530 | 4.59 |
Mark1 |
MAP/microtubule affinity regulating kinase 1 |
1557 |
0.41 |
chr7_29314313_29315903 | 4.58 |
Dpf1 |
D4, zinc and double PHD fingers family 1 |
45 |
0.96 |
chr6_45060808_45060959 | 4.56 |
Cntnap2 |
contactin associated protein-like 2 |
822 |
0.6 |
chr8_54958887_54959474 | 4.56 |
Gm45263 |
predicted gene 45263 |
639 |
0.67 |
chr18_25750468_25751272 | 4.54 |
Celf4 |
CUGBP, Elav-like family member 4 |
1822 |
0.41 |
chr2_65932868_65933620 | 4.53 |
Csrnp3 |
cysteine-serine-rich nuclear protein 3 |
1379 |
0.47 |
chr8_17532221_17533470 | 4.52 |
Csmd1 |
CUB and Sushi multiple domains 1 |
2436 |
0.46 |
chr6_55679226_55679709 | 4.50 |
Neurod6 |
neurogenic differentiation 6 |
1796 |
0.39 |
chr1_92849002_92850443 | 4.50 |
Mir149 |
microRNA 149 |
656 |
0.43 |
chr7_126274826_126275043 | 4.49 |
Sbk1 |
SH3-binding kinase 1 |
1534 |
0.28 |
chr2_25580658_25582212 | 4.47 |
Ajm1 |
apical junction component 1 |
293 |
0.72 |
chr12_31713469_31714088 | 4.44 |
Gpr22 |
G protein-coupled receptor 22 |
148 |
0.95 |
chr1_72533122_72533871 | 4.41 |
Marchf4 |
membrane associated ring-CH-type finger 4 |
3434 |
0.27 |
chr19_38265533_38266016 | 4.41 |
Lgi1 |
leucine-rich repeat LGI family, member 1 |
364 |
0.85 |
chr16_81203792_81204456 | 4.40 |
Ncam2 |
neural cell adhesion molecule 2 |
3367 |
0.33 |
chr9_96731522_96733329 | 4.40 |
Zbtb38 |
zinc finger and BTB domain containing 38 |
244 |
0.91 |
chr11_29376424_29376575 | 4.39 |
Ccdc88a |
coiled coil domain containing 88A |
2151 |
0.25 |
chr1_99774315_99774575 | 4.38 |
Cntnap5b |
contactin associated protein-like 5B |
1680 |
0.43 |
chr5_131614206_131615000 | 4.38 |
2810432F15Rik |
RIKEN cDNA 2810432F15 gene |
835 |
0.43 |
chr8_10155630_10156153 | 4.37 |
Myo16 |
myosin XVI |
1923 |
0.43 |
chr9_112232067_112232798 | 4.36 |
Arpp21 |
cyclic AMP-regulated phosphoprotein, 21 |
69 |
0.97 |
chr12_52699823_52700029 | 4.35 |
Akap6 |
A kinase (PRKA) anchor protein 6 |
543 |
0.8 |
chr18_64890376_64890890 | 4.32 |
Nedd4l |
neural precursor cell expressed, developmentally down-regulated gene 4-like |
140 |
0.95 |
chr7_126276115_126276973 | 4.32 |
Sbk1 |
SH3-binding kinase 1 |
3144 |
0.16 |
chr6_77243534_77244121 | 4.32 |
Lrrtm1 |
leucine rich repeat transmembrane neuronal 1 |
905 |
0.69 |
chr3_79144294_79146166 | 4.32 |
Rapgef2 |
Rap guanine nucleotide exchange factor (GEF) 2 |
253 |
0.94 |
chr14_124675118_124677112 | 4.31 |
Fgf14 |
fibroblast growth factor 14 |
1012 |
0.63 |
chr7_109165724_109166870 | 4.30 |
Lmo1 |
LIM domain only 1 |
4215 |
0.21 |
chr4_28935438_28936019 | 4.28 |
Epha7 |
Eph receptor A7 |
63804 |
0.13 |
chr10_12612327_12612570 | 4.27 |
Utrn |
utrophin |
2383 |
0.42 |
chr13_109442519_109443753 | 4.26 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
953 |
0.73 |
chrX_7919510_7921219 | 4.25 |
Pcsk1n |
proprotein convertase subtilisin/kexin type 1 inhibitor |
542 |
0.52 |
chr12_49386539_49386878 | 4.25 |
Gm43517 |
predicted gene 43517 |
1534 |
0.27 |
chr4_13748542_13748715 | 4.24 |
Runx1t1 |
RUNX1 translocation partner 1 |
2669 |
0.4 |
chr13_99443316_99444666 | 4.23 |
Map1b |
microtubule-associated protein 1B |
47 |
0.98 |
chr3_34562856_34563429 | 4.22 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
2750 |
0.22 |
chr13_36732776_36733340 | 4.22 |
Nrn1 |
neuritin 1 |
1312 |
0.4 |
chr1_6760592_6761327 | 4.21 |
St18 |
suppression of tumorigenicity 18 |
23384 |
0.23 |
chr3_16938563_16939069 | 4.18 |
Gm26485 |
predicted gene, 26485 |
115504 |
0.07 |
chr6_110649216_110650077 | 4.15 |
Gm20387 |
predicted gene 20387 |
3730 |
0.27 |
chr17_91086370_91086959 | 4.15 |
Gm47307 |
predicted gene, 47307 |
1742 |
0.26 |
chr7_19175632_19177533 | 4.15 |
Eml2 |
echinoderm microtubule associated protein like 2 |
161 |
0.88 |
chr7_137305711_137306880 | 4.15 |
Ebf3 |
early B cell factor 3 |
7621 |
0.2 |
chr3_29083980_29084375 | 4.15 |
Egfem1 |
EGF-like and EMI domain containing 1 |
1406 |
0.54 |
chr10_119692967_119693192 | 4.13 |
Grip1 |
glutamate receptor interacting protein 1 |
1025 |
0.57 |
chr3_66746318_66747483 | 4.13 |
Gm6555 |
predicted gene 6555 |
135450 |
0.05 |
chr8_112570000_112570856 | 4.12 |
Cntnap4 |
contactin associated protein-like 4 |
373 |
0.76 |
chr15_92598307_92599654 | 4.09 |
Pdzrn4 |
PDZ domain containing RING finger 4 |
1854 |
0.49 |
chr6_144206365_144207010 | 4.09 |
Sox5 |
SRY (sex determining region Y)-box 5 |
2260 |
0.45 |
chr17_8388660_8390136 | 4.08 |
Gm5491 |
predicted gene 5491 |
4738 |
0.15 |
chr7_60047531_60048075 | 4.07 |
Snrpn |
small nuclear ribonucleoprotein N |
42692 |
0.06 |
chr17_51810341_51810720 | 4.06 |
Satb1 |
special AT-rich sequence binding protein 1 |
389 |
0.75 |
chr16_77420100_77420782 | 4.05 |
9430053O09Rik |
RIKEN cDNA 9430053O09 gene |
1379 |
0.28 |
chr19_59467055_59468700 | 4.05 |
Emx2 |
empty spiracles homeobox 2 |
5075 |
0.18 |
chr8_41054160_41054452 | 4.05 |
Mtus1 |
mitochondrial tumor suppressor 1 |
477 |
0.69 |
chr3_31309226_31310664 | 4.05 |
Slc7a14 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 14 |
433 |
0.72 |
chr10_12613847_12614341 | 4.04 |
Utrn |
utrophin |
737 |
0.78 |
chr18_37089669_37090791 | 4.04 |
Pcdhac1 |
protocadherin alpha subfamily C, 1 |
217 |
0.88 |
chr7_93083157_93083738 | 4.03 |
Gm9934 |
predicted gene 9934 |
2420 |
0.25 |
chr3_88213113_88214199 | 4.00 |
Gm3764 |
predicted gene 3764 |
829 |
0.3 |
chr6_12259140_12259993 | 3.99 |
Thsd7a |
thrombospondin, type I, domain containing 7A |
58763 |
0.15 |
chr2_96319240_96319943 | 3.99 |
Lrrc4c |
leucine rich repeat containing 4C |
1375 |
0.61 |
chr2_62046631_62048214 | 3.98 |
Slc4a10 |
solute carrier family 4, sodium bicarbonate cotransporter-like, member 10 |
777 |
0.76 |
chr1_66324716_66324867 | 3.98 |
Map2 |
microtubule-associated protein 2 |
2689 |
0.25 |
chr19_8838893_8839483 | 3.98 |
Gng3 |
guanine nucleotide binding protein (G protein), gamma 3 |
6 |
0.61 |
chr2_49633149_49633710 | 3.97 |
Kif5c |
kinesin family member 5C |
14131 |
0.24 |
chr7_128690432_128691249 | 3.96 |
Gm16044 |
predicted gene 16044 |
1849 |
0.17 |
chr3_148976888_148978178 | 3.96 |
Gm43573 |
predicted gene 43573 |
11619 |
0.18 |
chr10_32887518_32887881 | 3.95 |
Nkain2 |
Na+/K+ transporting ATPase interacting 2 |
1997 |
0.43 |
chr2_97471929_97472576 | 3.95 |
Lrrc4c |
leucine rich repeat containing 4C |
4163 |
0.36 |
chr3_146769678_146770812 | 3.95 |
Prkacb |
protein kinase, cAMP dependent, catalytic, beta |
16 |
0.98 |
chr9_41585694_41587243 | 3.95 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
1301 |
0.29 |
chr7_60449424_60450258 | 3.95 |
Gm30196 |
predicted gene, 30196 |
156637 |
0.03 |
chr5_66747744_66748929 | 3.94 |
Limch1 |
LIM and calponin homology domains 1 |
2447 |
0.26 |
chr15_72807706_72808811 | 3.93 |
Peg13 |
paternally expressed 13 |
2066 |
0.4 |
chr10_73096427_73097649 | 3.91 |
Pcdh15 |
protocadherin 15 |
2304 |
0.33 |
chr11_80478619_80479391 | 3.91 |
Cdk5r1 |
cyclin-dependent kinase 5, regulatory subunit 1 (p35) |
1949 |
0.32 |
chr9_112231189_112232055 | 3.90 |
Arpp21 |
cyclic AMP-regulated phosphoprotein, 21 |
280 |
0.9 |
chrX_23284413_23285126 | 3.90 |
Klhl13 |
kelch-like 13 |
60 |
0.99 |
chr5_120425610_120425983 | 3.88 |
Lhx5 |
LIM homeobox protein 5 |
5903 |
0.14 |
chr13_39524050_39524578 | 3.84 |
Gm47351 |
predicted gene, 47351 |
8789 |
0.2 |
chr1_120604474_120605877 | 3.84 |
En1 |
engrailed 1 |
2757 |
0.3 |
chr8_31915119_31915654 | 3.82 |
Nrg1 |
neuregulin 1 |
2264 |
0.34 |
chr1_42688699_42689514 | 3.82 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
3987 |
0.16 |
chr9_52676918_52677560 | 3.81 |
AI593442 |
expressed sequence AI593442 |
2190 |
0.3 |
chr4_91399504_91400258 | 3.81 |
Elavl2 |
ELAV like RNA binding protein 1 |
95 |
0.97 |
chr7_90386713_90387752 | 3.81 |
Sytl2 |
synaptotagmin-like 2 |
127 |
0.96 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.3 | 13.0 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
3.6 | 10.9 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
3.3 | 10.0 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
3.0 | 9.0 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
2.9 | 8.8 | GO:0046684 | response to pyrethroid(GO:0046684) |
2.7 | 8.1 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
2.4 | 14.6 | GO:0042118 | endothelial cell activation(GO:0042118) |
2.3 | 21.0 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
2.3 | 14.0 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
2.3 | 9.2 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
2.3 | 15.9 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
2.3 | 6.8 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
2.2 | 4.5 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
2.2 | 6.7 | GO:0097113 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
2.2 | 15.5 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
2.2 | 6.6 | GO:0007525 | somatic muscle development(GO:0007525) |
2.2 | 6.6 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
2.2 | 6.6 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
2.0 | 22.1 | GO:0071625 | vocalization behavior(GO:0071625) |
2.0 | 5.9 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
1.9 | 9.6 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
1.9 | 7.7 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
1.9 | 3.8 | GO:0045914 | negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
1.8 | 5.5 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
1.8 | 3.7 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
1.8 | 7.3 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
1.8 | 14.6 | GO:0021860 | pyramidal neuron development(GO:0021860) |
1.8 | 5.4 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
1.8 | 3.6 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
1.7 | 1.7 | GO:0061642 | chemoattraction of axon(GO:0061642) |
1.7 | 5.2 | GO:0001661 | conditioned taste aversion(GO:0001661) |
1.6 | 6.5 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
1.6 | 1.6 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
1.6 | 3.2 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
1.6 | 4.8 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
1.6 | 3.2 | GO:0072578 | neurotransmitter-gated ion channel clustering(GO:0072578) |
1.6 | 6.3 | GO:0030035 | microspike assembly(GO:0030035) |
1.6 | 6.3 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) |
1.6 | 6.3 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
1.5 | 4.6 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
1.5 | 7.6 | GO:0016198 | axon choice point recognition(GO:0016198) |
1.5 | 10.6 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
1.4 | 11.4 | GO:0097120 | receptor localization to synapse(GO:0097120) |
1.4 | 17.0 | GO:0035418 | protein localization to synapse(GO:0035418) |
1.4 | 5.6 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
1.4 | 9.5 | GO:0097264 | self proteolysis(GO:0097264) |
1.3 | 3.9 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
1.3 | 6.5 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
1.3 | 6.5 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
1.3 | 5.1 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
1.3 | 10.1 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
1.3 | 31.3 | GO:0001964 | startle response(GO:0001964) |
1.2 | 6.1 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
1.2 | 13.1 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
1.2 | 2.4 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
1.2 | 3.5 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
1.2 | 1.2 | GO:0042706 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
1.2 | 2.3 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
1.2 | 3.5 | GO:0060166 | olfactory pit development(GO:0060166) |
1.1 | 4.6 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
1.1 | 1.1 | GO:0090493 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
1.1 | 8.9 | GO:0071420 | cellular response to histamine(GO:0071420) |
1.1 | 3.3 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
1.1 | 2.2 | GO:0035262 | gonad morphogenesis(GO:0035262) |
1.1 | 3.2 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
1.1 | 5.3 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
1.1 | 18.0 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
1.1 | 3.2 | GO:0097090 | presynaptic membrane organization(GO:0097090) |
1.0 | 1.0 | GO:0072144 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
1.0 | 3.1 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
1.0 | 3.1 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
1.0 | 5.1 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
1.0 | 9.1 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
1.0 | 1.0 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
1.0 | 15.9 | GO:0060074 | synapse maturation(GO:0060074) |
1.0 | 9.9 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
1.0 | 4.9 | GO:0038107 | nodal signaling pathway involved in determination of left/right asymmetry(GO:0038107) regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry(GO:1900094) nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900164) |
1.0 | 11.7 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
1.0 | 2.9 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
1.0 | 3.8 | GO:0007258 | JUN phosphorylation(GO:0007258) |
1.0 | 2.9 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.9 | 1.9 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.9 | 5.6 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.9 | 0.9 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.9 | 4.6 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.9 | 3.7 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.9 | 4.6 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.9 | 4.6 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.9 | 1.8 | GO:0098597 | observational learning(GO:0098597) |
0.9 | 2.7 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.9 | 3.6 | GO:0060174 | limb bud formation(GO:0060174) |
0.9 | 3.5 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
0.9 | 1.8 | GO:1901166 | neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
0.9 | 3.4 | GO:0030091 | protein repair(GO:0030091) |
0.9 | 2.6 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.9 | 3.4 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.8 | 2.5 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.8 | 2.5 | GO:0035106 | operant conditioning(GO:0035106) |
0.8 | 0.8 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.8 | 7.5 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.8 | 2.5 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.8 | 2.5 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.8 | 3.3 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.8 | 2.4 | GO:0021898 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.8 | 0.8 | GO:0021586 | pons maturation(GO:0021586) |
0.8 | 1.6 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.8 | 3.1 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.8 | 3.9 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.8 | 1.5 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.8 | 3.1 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.8 | 0.8 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.8 | 2.3 | GO:2000836 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.8 | 1.5 | GO:0048880 | sensory system development(GO:0048880) |
0.8 | 1.5 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.7 | 0.7 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.7 | 0.7 | GO:0071899 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.7 | 3.7 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.7 | 1.5 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.7 | 2.2 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.7 | 2.2 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.7 | 2.9 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.7 | 1.4 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.7 | 2.1 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.7 | 9.2 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.7 | 8.3 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.7 | 1.4 | GO:0061743 | motor learning(GO:0061743) |
0.7 | 1.3 | GO:0035696 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
0.7 | 3.3 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.7 | 0.7 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.7 | 32.3 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.7 | 3.9 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.6 | 1.9 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.6 | 2.6 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.6 | 3.8 | GO:0086018 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
0.6 | 0.6 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.6 | 3.7 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.6 | 1.2 | GO:0043309 | regulation of eosinophil degranulation(GO:0043309) |
0.6 | 4.8 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.6 | 1.2 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
0.6 | 3.0 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.6 | 1.2 | GO:0051464 | positive regulation of cortisol secretion(GO:0051464) |
0.6 | 2.9 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.6 | 4.1 | GO:0060539 | diaphragm development(GO:0060539) |
0.6 | 1.2 | GO:0060594 | mammary gland specification(GO:0060594) |
0.6 | 1.7 | GO:0060023 | soft palate development(GO:0060023) |
0.6 | 2.9 | GO:0045852 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.6 | 4.0 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.6 | 1.7 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.6 | 1.7 | GO:0022038 | corpus callosum development(GO:0022038) |
0.6 | 2.3 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.6 | 4.5 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.6 | 1.7 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
0.6 | 1.7 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.6 | 1.1 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.6 | 9.9 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.5 | 1.1 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.5 | 1.6 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.5 | 1.6 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.5 | 2.6 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.5 | 2.6 | GO:0072017 | distal tubule development(GO:0072017) |
0.5 | 7.7 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.5 | 0.5 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.5 | 0.5 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.5 | 2.0 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.5 | 11.5 | GO:0006491 | N-glycan processing(GO:0006491) |
0.5 | 2.5 | GO:0060179 | male mating behavior(GO:0060179) |
0.5 | 1.5 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.5 | 2.0 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.5 | 2.0 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.5 | 1.0 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.5 | 2.0 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.5 | 3.0 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.5 | 1.0 | GO:0072093 | metanephric renal vesicle formation(GO:0072093) |
0.5 | 0.5 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.5 | 1.5 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.5 | 1.5 | GO:0008292 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.5 | 2.9 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.5 | 2.4 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.5 | 1.0 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.5 | 6.7 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.5 | 1.0 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.5 | 34.7 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.5 | 5.2 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.5 | 1.9 | GO:0021877 | forebrain neuron fate commitment(GO:0021877) |
0.5 | 2.8 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.5 | 0.5 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.5 | 3.7 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.5 | 2.8 | GO:0045176 | apical protein localization(GO:0045176) |
0.4 | 4.0 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
0.4 | 1.3 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.4 | 1.3 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.4 | 0.9 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.4 | 0.4 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
0.4 | 1.3 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.4 | 3.5 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.4 | 3.5 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.4 | 1.3 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.4 | 0.4 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.4 | 2.1 | GO:2001054 | negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
0.4 | 0.8 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.4 | 1.7 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.4 | 1.3 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.4 | 0.4 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.4 | 1.2 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.4 | 1.2 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.4 | 1.2 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.4 | 2.0 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.4 | 6.1 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.4 | 0.4 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.4 | 0.4 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.4 | 1.6 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.4 | 2.0 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.4 | 2.0 | GO:0030432 | peristalsis(GO:0030432) |
0.4 | 1.2 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.4 | 0.4 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.4 | 1.2 | GO:1903288 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
0.4 | 2.0 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.4 | 0.4 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.4 | 0.8 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.4 | 1.2 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.4 | 0.4 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.4 | 0.8 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.4 | 0.8 | GO:0032811 | negative regulation of epinephrine secretion(GO:0032811) |
0.4 | 1.2 | GO:0060005 | vestibular reflex(GO:0060005) |
0.4 | 0.8 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.4 | 1.1 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.4 | 1.5 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.4 | 0.8 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.4 | 1.1 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
0.4 | 5.6 | GO:0007416 | synapse assembly(GO:0007416) |
0.4 | 1.5 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.4 | 4.1 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.4 | 0.7 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.4 | 0.7 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
0.4 | 3.7 | GO:0003334 | keratinocyte development(GO:0003334) |
0.4 | 6.9 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.4 | 1.8 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
0.4 | 2.5 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.4 | 1.1 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.4 | 0.4 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.4 | 2.9 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.4 | 1.1 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.4 | 1.4 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.4 | 0.4 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.4 | 1.1 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.4 | 8.4 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.3 | 1.7 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.3 | 0.7 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.3 | 1.4 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.3 | 1.0 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.3 | 1.7 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.3 | 1.0 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.3 | 0.7 | GO:1903596 | regulation of gap junction assembly(GO:1903596) |
0.3 | 1.4 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.3 | 2.4 | GO:1902287 | semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.3 | 7.1 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.3 | 0.3 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.3 | 2.7 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.3 | 2.3 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.3 | 0.7 | GO:1901535 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.3 | 0.7 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.3 | 3.0 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.3 | 1.6 | GO:0001978 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) |
0.3 | 0.3 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.3 | 1.6 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.3 | 0.7 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.3 | 1.0 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.3 | 0.6 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.3 | 3.5 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.3 | 0.6 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.3 | 0.3 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.3 | 0.6 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.3 | 2.5 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.3 | 2.5 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.3 | 1.9 | GO:0060384 | innervation(GO:0060384) |
0.3 | 1.5 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.3 | 0.9 | GO:0015755 | fructose transport(GO:0015755) |
0.3 | 0.9 | GO:0030242 | pexophagy(GO:0030242) |
0.3 | 1.2 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.3 | 0.6 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.3 | 1.8 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.3 | 0.6 | GO:0061197 | fungiform papilla morphogenesis(GO:0061197) fungiform papilla formation(GO:0061198) |
0.3 | 0.3 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.3 | 3.0 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.3 | 1.2 | GO:0042891 | antibiotic transport(GO:0042891) |
0.3 | 0.6 | GO:0009629 | response to gravity(GO:0009629) |
0.3 | 19.1 | GO:0007612 | learning(GO:0007612) |
0.3 | 2.6 | GO:0001553 | luteinization(GO:0001553) |
0.3 | 0.6 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.3 | 0.9 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.3 | 0.9 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.3 | 0.9 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.3 | 1.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.3 | 0.6 | GO:0003257 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) |
0.3 | 0.3 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.3 | 1.7 | GO:0022010 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.3 | 0.8 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.3 | 1.1 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.3 | 2.5 | GO:0007616 | long-term memory(GO:0007616) |
0.3 | 1.1 | GO:0021794 | thalamus development(GO:0021794) |
0.3 | 0.5 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.3 | 1.9 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.3 | 1.1 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.3 | 0.8 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.3 | 0.8 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.3 | 1.1 | GO:0046909 | intermembrane transport(GO:0046909) |
0.3 | 0.5 | GO:0032439 | endosome localization(GO:0032439) |
0.3 | 1.0 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.3 | 0.5 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.3 | 0.3 | GO:1903276 | regulation of sodium ion export(GO:1903273) regulation of sodium ion export from cell(GO:1903276) |
0.3 | 1.8 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.3 | 0.5 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.3 | 0.3 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
0.3 | 1.3 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.3 | 1.3 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.3 | 0.3 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.3 | 0.8 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.3 | 0.3 | GO:0072497 | mesenchymal stem cell differentiation(GO:0072497) |
0.2 | 0.7 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.2 | 0.5 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.2 | 15.3 | GO:0007411 | axon guidance(GO:0007411) |
0.2 | 0.5 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.2 | 7.6 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.2 | 0.7 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.2 | 0.5 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.2 | 0.7 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.2 | 1.2 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.2 | 0.5 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.2 | 0.7 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.2 | 0.2 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.2 | 0.9 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.2 | 0.5 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.2 | 0.7 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.2 | 1.2 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.2 | 0.7 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.2 | 0.2 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.2 | 0.5 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.2 | 0.7 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.2 | 0.9 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.2 | 0.5 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.2 | 0.5 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.2 | 1.6 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.2 | 2.3 | GO:0034389 | lipid particle organization(GO:0034389) |
0.2 | 0.7 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.2 | 0.5 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.2 | 1.1 | GO:0015816 | glycine transport(GO:0015816) |
0.2 | 0.2 | GO:0007632 | visual behavior(GO:0007632) |
0.2 | 0.5 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.2 | 0.7 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.2 | 0.2 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.2 | 0.5 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.2 | 0.7 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.2 | 0.4 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.2 | 0.2 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.2 | 6.0 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.2 | 0.7 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.2 | 0.2 | GO:0072038 | mesenchymal stem cell maintenance involved in nephron morphogenesis(GO:0072038) |
0.2 | 1.1 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.2 | 1.5 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.2 | 0.2 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.2 | 0.2 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.2 | 0.6 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
0.2 | 0.2 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.2 | 0.4 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.2 | 1.5 | GO:0070417 | cellular response to cold(GO:0070417) |
0.2 | 1.7 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.2 | 0.2 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.2 | 0.4 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.2 | 0.8 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.2 | 2.3 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.2 | 1.0 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.2 | 0.4 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.2 | 0.4 | GO:0090135 | actin filament branching(GO:0090135) |
0.2 | 0.2 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.2 | 1.0 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.2 | 0.4 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.2 | 4.4 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.2 | 0.6 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.2 | 1.0 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.2 | 0.4 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.2 | 0.2 | GO:0015744 | succinate transport(GO:0015744) |
0.2 | 0.6 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.2 | 0.6 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.2 | 7.8 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.2 | 1.7 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.2 | 2.7 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.2 | 0.6 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.2 | 0.4 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.2 | 11.1 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.2 | 0.6 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.2 | 1.1 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.2 | 0.8 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.2 | 0.4 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.2 | 0.7 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.2 | 1.3 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.2 | 0.7 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.2 | 1.3 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.2 | 0.2 | GO:0071609 | chemokine (C-C motif) ligand 5 production(GO:0071609) |
0.2 | 0.4 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.2 | 1.1 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.2 | 1.1 | GO:0014741 | negative regulation of muscle hypertrophy(GO:0014741) |
0.2 | 0.4 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.2 | 0.4 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.2 | 0.9 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.2 | 1.1 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.2 | 0.2 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.2 | 0.5 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.2 | 15.6 | GO:0071805 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.2 | 1.6 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.2 | 0.2 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.2 | 0.9 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.2 | 0.5 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.2 | 0.3 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
0.2 | 0.7 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.2 | 1.2 | GO:0007097 | nuclear migration(GO:0007097) |
0.2 | 0.2 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.2 | 0.3 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.2 | 0.7 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.2 | 0.3 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.2 | 0.7 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.2 | 0.7 | GO:0048265 | response to pain(GO:0048265) |
0.2 | 0.3 | GO:1900127 | positive regulation of hyaluronan biosynthetic process(GO:1900127) |
0.2 | 0.5 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.2 | 0.6 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.2 | 0.5 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.2 | 0.6 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.2 | 0.5 | GO:0015808 | L-alanine transport(GO:0015808) |
0.2 | 0.2 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.2 | 0.6 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.2 | 0.3 | GO:0014028 | notochord formation(GO:0014028) |
0.2 | 0.2 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
0.2 | 0.2 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.2 | 0.6 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.2 | 0.5 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.2 | 1.2 | GO:1904152 | regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
0.2 | 0.5 | GO:0051182 | coenzyme transport(GO:0051182) |
0.2 | 0.6 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.2 | 2.3 | GO:0050905 | neuromuscular process(GO:0050905) |
0.2 | 0.5 | GO:0032202 | telomere assembly(GO:0032202) |
0.2 | 0.5 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.2 | 0.8 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.2 | 0.6 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.2 | 2.6 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.6 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.1 | 0.4 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.1 | 1.3 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.1 | 0.1 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.1 | 0.3 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.1 | 0.3 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.1 | 0.3 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.1 | 0.6 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 0.1 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.1 | 0.3 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.1 | 0.3 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.1 | 0.3 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.1 | 1.0 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.1 | 0.3 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.1 | 4.2 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.1 | 1.2 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.1 | 1.2 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.1 | 1.1 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.1 | 0.1 | GO:0044849 | estrous cycle(GO:0044849) |
0.1 | 0.1 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.1 | 0.1 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.1 | 0.3 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 1.1 | GO:0072112 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.1 | 3.6 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.1 | 0.9 | GO:0017014 | protein nitrosylation(GO:0017014) |
0.1 | 0.9 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.1 | 1.1 | GO:0072501 | cellular divalent inorganic anion homeostasis(GO:0072501) |
0.1 | 0.5 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 0.9 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 3.9 | GO:0050808 | synapse organization(GO:0050808) |
0.1 | 0.3 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.1 | 0.4 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.1 | 0.9 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 0.6 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 0.1 | GO:1904023 | regulation of fermentation(GO:0043465) regulation of NAD metabolic process(GO:1902688) regulation of glucose catabolic process to lactate via pyruvate(GO:1904023) |
0.1 | 0.4 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.1 | 3.4 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.6 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.1 | 0.1 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.1 | 0.7 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
0.1 | 0.4 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 0.4 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.1 | 0.7 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.1 | 0.6 | GO:0021766 | hippocampus development(GO:0021766) |
0.1 | 5.8 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.2 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.1 | 0.4 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 0.5 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.1 | 0.2 | GO:0060242 | contact inhibition(GO:0060242) |
0.1 | 0.2 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.1 | 0.1 | GO:0070671 | response to interleukin-12(GO:0070671) |
0.1 | 0.3 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.1 | 0.2 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.1 | 1.1 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.1 | 0.5 | GO:0002249 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.1 | 0.6 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.1 | 1.6 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.1 | 0.4 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.1 | 0.2 | GO:0046931 | pore complex assembly(GO:0046931) |
0.1 | 0.4 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.1 | 0.4 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.6 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.1 | 0.2 | GO:0008050 | female courtship behavior(GO:0008050) |
0.1 | 0.6 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.1 | 1.0 | GO:0015800 | acidic amino acid transport(GO:0015800) |
0.1 | 0.5 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.1 | 0.8 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.1 | 0.5 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.1 | 1.6 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.1 | 0.2 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.1 | 0.7 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 0.2 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.1 | 4.0 | GO:0099531 | presynaptic process involved in chemical synaptic transmission(GO:0099531) |
0.1 | 0.9 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.1 | 1.6 | GO:0021549 | cerebellum development(GO:0021549) |
0.1 | 0.4 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 0.1 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.1 | 0.1 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.1 | 0.2 | GO:0050427 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.1 | 0.4 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.1 | 0.2 | GO:0001555 | oocyte growth(GO:0001555) |
0.1 | 0.1 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.1 | 1.5 | GO:0048240 | sperm capacitation(GO:0048240) |
0.1 | 0.1 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.1 | 0.4 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 6.9 | GO:0048015 | phosphatidylinositol-mediated signaling(GO:0048015) |
0.1 | 0.1 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.1 | 0.2 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.3 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.1 | 0.2 | GO:0014002 | astrocyte development(GO:0014002) |
0.1 | 0.1 | GO:0048570 | notochord morphogenesis(GO:0048570) |
0.1 | 0.3 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 2.2 | GO:0007340 | acrosome reaction(GO:0007340) |
0.1 | 0.1 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 1.8 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.1 | 0.4 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.1 | 0.5 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.1 | 0.1 | GO:0051588 | regulation of neurotransmitter transport(GO:0051588) |
0.1 | 0.3 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.1 | 0.2 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.1 | 0.3 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 0.3 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.5 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 0.5 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 0.5 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.1 | 0.7 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.1 | 0.3 | GO:0048254 | snoRNA localization(GO:0048254) |
0.1 | 0.3 | GO:1900113 | regulation of histone H3-K9 trimethylation(GO:1900112) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.1 | 0.2 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.1 | 0.4 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.1 | 0.2 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.1 | 0.2 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.1 | 0.7 | GO:0006228 | UTP biosynthetic process(GO:0006228) UTP metabolic process(GO:0046051) |
0.1 | 2.1 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.1 | 0.4 | GO:1902267 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.1 | 0.2 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.1 | 0.1 | GO:2000143 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.1 | 0.1 | GO:0002339 | B cell selection(GO:0002339) |
0.1 | 0.4 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.1 | 0.1 | GO:0045354 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.1 | 0.5 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 1.1 | GO:0051294 | establishment of spindle orientation(GO:0051294) |
0.1 | 0.8 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.1 | 0.1 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.1 | 0.4 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.1 | 0.2 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.1 | 0.2 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.1 | 0.2 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.1 | 0.7 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.6 | GO:0043113 | receptor clustering(GO:0043113) |
0.1 | 0.5 | GO:0002591 | positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.1 | 0.1 | GO:0031126 | snoRNA 3'-end processing(GO:0031126) |
0.1 | 0.1 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.1 | 0.1 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.1 | 0.2 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.1 | 0.2 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.1 | 0.3 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.1 | 0.6 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.1 | 0.1 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 0.2 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.1 | 0.2 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.1 | 0.3 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.1 | 0.2 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.1 | 0.1 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
0.1 | 0.4 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.2 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 0.1 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.1 | 0.2 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.3 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.1 | 0.5 | GO:0051231 | spindle elongation(GO:0051231) |
0.1 | 0.1 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.1 | 0.1 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.1 | 0.2 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.1 | 0.1 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
0.1 | 0.1 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.1 | 0.2 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 0.1 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.1 | 1.6 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.1 | 0.3 | GO:0060253 | negative regulation of glial cell proliferation(GO:0060253) |
0.1 | 0.1 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.1 | 0.3 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.1 | 0.1 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.1 | 0.1 | GO:0060534 | trachea cartilage development(GO:0060534) |
0.1 | 0.1 | GO:0019401 | alditol biosynthetic process(GO:0019401) |
0.1 | 0.2 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.1 | 0.1 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.1 | 0.2 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.1 | 0.1 | GO:0061588 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.1 | 0.1 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.1 | 0.5 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.1 | 0.2 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 0.2 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.1 | 0.1 | GO:0032650 | regulation of interleukin-1 alpha production(GO:0032650) |
0.1 | 0.2 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.1 | 0.4 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.1 | 0.3 | GO:0048478 | replication fork protection(GO:0048478) |
0.1 | 0.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 0.3 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
0.1 | 0.1 | GO:0035933 | glucocorticoid secretion(GO:0035933) regulation of glucocorticoid secretion(GO:2000849) |
0.1 | 0.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.2 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.1 | 0.2 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 0.2 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 0.2 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.1 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.2 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.1 | 0.3 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 0.2 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 0.5 | GO:0042407 | cristae formation(GO:0042407) |
0.1 | 0.1 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.1 | 0.1 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.1 | 0.1 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.1 | 0.1 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.1 | 0.6 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 0.1 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
0.1 | 0.4 | GO:1990403 | embryonic brain development(GO:1990403) |
0.1 | 0.2 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.1 | 0.2 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.1 | 0.2 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.1 | 0.3 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.1 | 0.3 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.1 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.1 | 0.2 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.1 | 0.1 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.1 | 0.1 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.1 | 0.2 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.0 | 0.2 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.0 | 0.2 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.0 | 0.2 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.0 | 0.1 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.0 | 0.2 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.0 | 0.2 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.0 | 0.2 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.0 | GO:0071868 | cellular response to monoamine stimulus(GO:0071868) |
0.0 | 0.0 | GO:1904587 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.0 | 0.2 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.0 | 0.4 | GO:0045687 | positive regulation of glial cell differentiation(GO:0045687) |
0.0 | 0.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.0 | GO:0015819 | lysine transport(GO:0015819) |
0.0 | 0.2 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.0 | 0.2 | GO:0042546 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.0 | 0.3 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.0 | 0.0 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.0 | 0.0 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.0 | 0.1 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.0 | 1.0 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.0 | 0.1 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.0 | 0.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.0 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.0 | 0.1 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.0 | 0.1 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.0 | 0.0 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.0 | 0.2 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.0 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.0 | 0.1 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.0 | 0.1 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.0 | 0.2 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.0 | 0.2 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.0 | 0.0 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.0 | 0.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.1 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.0 | 0.1 | GO:1900378 | regulation of melanin biosynthetic process(GO:0048021) positive regulation of melanin biosynthetic process(GO:0048023) regulation of secondary metabolite biosynthetic process(GO:1900376) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.0 | 0.0 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.0 | 0.1 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.0 | 0.1 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.0 | 0.1 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.0 | 0.1 | GO:0046541 | saliva secretion(GO:0046541) |
0.0 | 0.4 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.1 | GO:0051177 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.0 | 0.2 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.0 | 0.1 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.0 | 0.2 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.0 | 0.4 | GO:0095500 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.0 | 0.1 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.0 | 0.0 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.0 | 0.0 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.0 | 0.1 | GO:0097503 | sialylation(GO:0097503) |
0.0 | 0.1 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.0 | 0.3 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.0 | 0.0 | GO:0070668 | mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.0 | 0.2 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.0 | 0.1 | GO:1902019 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.0 | 0.2 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.0 | 0.1 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.0 | 0.1 | GO:2000833 | positive regulation of steroid hormone secretion(GO:2000833) |
0.0 | 0.0 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.0 | 0.2 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.0 | 0.5 | GO:0050654 | chondroitin sulfate proteoglycan metabolic process(GO:0050654) |
0.0 | 0.0 | GO:0036476 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.0 | 0.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.0 | 0.1 | GO:2000197 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.0 | 0.2 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.0 | 0.4 | GO:0007588 | excretion(GO:0007588) |
0.0 | 0.2 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.0 | 0.0 | GO:0097499 | protein localization to nonmotile primary cilium(GO:0097499) |
0.0 | 0.2 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.0 | 0.1 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.0 | 0.1 | GO:0016074 | snoRNA metabolic process(GO:0016074) |
0.0 | 0.1 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.0 | 0.1 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.0 | 0.1 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.0 | 0.3 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.0 | 0.0 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
0.0 | 0.0 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
0.0 | 0.3 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.0 | 0.1 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.0 | 0.1 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
0.0 | 0.0 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.0 | 0.0 | GO:0071554 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.0 | 0.0 | GO:1903059 | regulation of protein lipidation(GO:1903059) |
0.0 | 0.0 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.0 | 0.3 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.0 | 0.1 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.0 | 0.1 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
0.0 | 0.0 | GO:0048290 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
0.0 | 0.2 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.0 | 0.1 | GO:0042482 | positive regulation of odontogenesis(GO:0042482) |
0.0 | 0.0 | GO:0002327 | immature B cell differentiation(GO:0002327) |
0.0 | 0.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.0 | 0.2 | GO:0031498 | chromatin disassembly(GO:0031498) |
0.0 | 0.1 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.0 | 0.8 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.1 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.0 | 0.0 | GO:0032610 | interleukin-1 alpha production(GO:0032610) |
0.0 | 0.0 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.0 | 0.1 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.0 | 0.0 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.0 | 0.1 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.0 | 0.1 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.0 | 0.1 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.0 | 0.2 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.0 | 0.2 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.0 | 0.0 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.0 | 0.1 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.0 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.0 | 0.0 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.0 | 0.0 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.0 | 0.1 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.0 | 0.0 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.0 | 0.0 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.0 | 0.0 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.0 | 0.4 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.0 | 0.1 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.0 | 0.2 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.1 | GO:0045916 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.0 | 0.0 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.0 | 0.0 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.0 | 0.0 | GO:1904181 | positive regulation of membrane depolarization(GO:1904181) |
0.0 | 0.1 | GO:0003091 | renal water homeostasis(GO:0003091) |
0.0 | 0.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 0.0 | GO:0009838 | abscission(GO:0009838) |
0.0 | 0.0 | GO:1900221 | regulation of beta-amyloid clearance(GO:1900221) |
0.0 | 0.0 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.0 | 0.0 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.0 | 0.0 | GO:0014821 | phasic smooth muscle contraction(GO:0014821) |
0.0 | 0.0 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.0 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.0 | 0.0 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.0 | 0.1 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.0 | 0.3 | GO:0046847 | filopodium assembly(GO:0046847) |
0.0 | 0.2 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.0 | 0.0 | GO:1901724 | positive regulation of cell proliferation involved in kidney development(GO:1901724) |
0.0 | 0.1 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.0 | 0.0 | GO:0002118 | aggressive behavior(GO:0002118) |
0.0 | 0.1 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.0 | 0.2 | GO:0044088 | regulation of vacuole organization(GO:0044088) |
0.0 | 0.1 | GO:1901984 | negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 6.4 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
1.9 | 5.7 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
1.9 | 3.8 | GO:0097441 | basilar dendrite(GO:0097441) |
1.8 | 18.4 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.8 | 5.5 | GO:0097451 | glial limiting end-foot(GO:0097451) |
1.7 | 20.3 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
1.6 | 11.2 | GO:0032584 | growth cone membrane(GO:0032584) |
1.6 | 6.3 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
1.6 | 12.5 | GO:0043083 | synaptic cleft(GO:0043083) |
1.6 | 7.8 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
1.5 | 10.2 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
1.4 | 20.7 | GO:0031527 | filopodium membrane(GO:0031527) |
1.3 | 24.1 | GO:0060077 | inhibitory synapse(GO:0060077) |
1.2 | 7.3 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
1.2 | 7.2 | GO:0043194 | axon initial segment(GO:0043194) |
1.2 | 8.4 | GO:0071437 | invadopodium(GO:0071437) |
1.2 | 7.0 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
1.1 | 3.3 | GO:0072534 | perineuronal net(GO:0072534) |
1.1 | 8.8 | GO:0042788 | polysomal ribosome(GO:0042788) |
1.1 | 27.5 | GO:0044295 | axonal growth cone(GO:0044295) |
1.1 | 28.1 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
1.1 | 1.1 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
1.0 | 3.9 | GO:0033010 | paranodal junction(GO:0033010) |
1.0 | 13.8 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
1.0 | 12.7 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
1.0 | 7.6 | GO:0097449 | astrocyte projection(GO:0097449) |
0.9 | 30.5 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.8 | 11.5 | GO:0071565 | nBAF complex(GO:0071565) |
0.8 | 33.3 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.8 | 10.1 | GO:0043196 | varicosity(GO:0043196) |
0.8 | 5.4 | GO:0030673 | axolemma(GO:0030673) |
0.7 | 5.1 | GO:0005883 | neurofilament(GO:0005883) |
0.7 | 16.6 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.7 | 4.1 | GO:0005915 | zonula adherens(GO:0005915) |
0.7 | 8.9 | GO:0032590 | dendrite membrane(GO:0032590) |
0.7 | 7.5 | GO:0031045 | dense core granule(GO:0031045) |
0.6 | 1.2 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.6 | 3.6 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.6 | 4.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.6 | 85.2 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.6 | 1.8 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.6 | 1.2 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.6 | 4.0 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.6 | 1.7 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.5 | 5.4 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.5 | 6.4 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.5 | 25.6 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.5 | 1.0 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.5 | 5.2 | GO:0035102 | PRC1 complex(GO:0035102) |
0.5 | 1.8 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.4 | 3.8 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.4 | 4.5 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.4 | 3.9 | GO:0005687 | U4 snRNP(GO:0005687) |
0.4 | 0.4 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.4 | 1.8 | GO:0097433 | dense body(GO:0097433) |
0.4 | 0.7 | GO:0032280 | symmetric synapse(GO:0032280) |
0.3 | 2.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.3 | 2.1 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.3 | 3.0 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.3 | 1.0 | GO:0043219 | lateral loop(GO:0043219) |
0.3 | 2.9 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.3 | 1.9 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.3 | 2.6 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.3 | 26.0 | GO:0030426 | growth cone(GO:0030426) |
0.3 | 0.6 | GO:0034706 | sodium channel complex(GO:0034706) |
0.3 | 2.8 | GO:0097440 | apical dendrite(GO:0097440) |
0.3 | 0.3 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.3 | 7.6 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.3 | 0.9 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.3 | 4.3 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.3 | 0.6 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.3 | 1.4 | GO:0070695 | FHF complex(GO:0070695) |
0.3 | 1.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.3 | 1.0 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.3 | 1.3 | GO:0097255 | R2TP complex(GO:0097255) |
0.3 | 0.8 | GO:0097427 | microtubule bundle(GO:0097427) |
0.2 | 1.7 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.2 | 14.6 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.2 | 1.0 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.2 | 1.4 | GO:0043203 | axon hillock(GO:0043203) |
0.2 | 1.8 | GO:0036157 | outer dynein arm(GO:0036157) |
0.2 | 0.5 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.2 | 0.4 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.2 | 0.2 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.2 | 1.9 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.2 | 13.2 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.2 | 1.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.2 | 0.2 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.2 | 6.5 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.2 | 0.4 | GO:0042585 | germinal vesicle(GO:0042585) |
0.2 | 0.6 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.2 | 2.4 | GO:0097225 | sperm midpiece(GO:0097225) |
0.2 | 0.4 | GO:1990635 | proximal dendrite(GO:1990635) |
0.2 | 0.5 | GO:0036396 | MIS complex(GO:0036396) |
0.2 | 0.7 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.2 | 1.6 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.2 | 0.3 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.2 | 10.8 | GO:0043204 | perikaryon(GO:0043204) |
0.2 | 0.5 | GO:0005745 | m-AAA complex(GO:0005745) |
0.2 | 5.3 | GO:0032420 | stereocilium(GO:0032420) |
0.2 | 0.3 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.2 | 36.3 | GO:0030425 | dendrite(GO:0030425) |
0.2 | 0.2 | GO:0031209 | SCAR complex(GO:0031209) |
0.2 | 1.0 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.2 | 0.5 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.2 | 2.2 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.2 | 1.1 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.2 | 0.6 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.2 | 0.3 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 20.0 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 5.9 | GO:0043679 | axon terminus(GO:0043679) |
0.1 | 1.0 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 0.4 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 1.0 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.3 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.1 | 0.9 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.1 | 1.3 | GO:0005858 | axonemal dynein complex(GO:0005858) inner dynein arm(GO:0036156) |
0.1 | 0.4 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 1.2 | GO:0097060 | synaptic membrane(GO:0097060) |
0.1 | 0.3 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 1.6 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.1 | 0.9 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.4 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.1 | 1.0 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.4 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.1 | 1.0 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.1 | 0.6 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 0.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 0.7 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 9.4 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 0.3 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.1 | 0.4 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 0.7 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.3 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 0.3 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 1.6 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 0.4 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 0.4 | GO:0033503 | HULC complex(GO:0033503) |
0.1 | 11.3 | GO:0045202 | synapse(GO:0045202) |
0.1 | 0.1 | GO:0000125 | PCAF complex(GO:0000125) |
0.1 | 0.5 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 0.5 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 0.7 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 0.1 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.1 | 0.8 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.4 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.1 | 0.3 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 1.1 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 0.2 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.4 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 0.2 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.1 | 1.6 | GO:0031513 | nonmotile primary cilium(GO:0031513) |
0.1 | 0.3 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.1 | 0.2 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.1 | 0.3 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.1 | 0.4 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.1 | 15.9 | GO:0043005 | neuron projection(GO:0043005) |
0.1 | 0.1 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 1.2 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.1 | 0.1 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 1.1 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 0.2 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 0.2 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 0.2 | GO:0000802 | transverse filament(GO:0000802) |
0.1 | 0.2 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 0.2 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 0.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 0.6 | GO:0044297 | cell body(GO:0044297) |
0.1 | 1.1 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 0.4 | GO:0032797 | SMN complex(GO:0032797) |
0.1 | 0.1 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.1 | 0.2 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 0.2 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 1.8 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.0 | 0.7 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.0 | 0.1 | GO:0071797 | LUBAC complex(GO:0071797) |
0.0 | 0.1 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 0.1 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.0 | 0.5 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 2.2 | GO:0034708 | methyltransferase complex(GO:0034708) |
0.0 | 0.2 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.0 | 0.3 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 0.2 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 0.5 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 0.2 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.0 | 0.3 | GO:0031011 | Ino80 complex(GO:0031011) |
0.0 | 0.1 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.0 | 0.1 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.0 | 0.6 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.1 | GO:0000235 | astral microtubule(GO:0000235) aster(GO:0005818) |
0.0 | 0.1 | GO:0030689 | Noc complex(GO:0030689) |
0.0 | 0.1 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.0 | 0.3 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.1 | GO:1990745 | EARP complex(GO:1990745) |
0.0 | 0.3 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.0 | 0.1 | GO:0042827 | platelet dense granule(GO:0042827) |
0.0 | 0.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.0 | 0.1 | GO:0098536 | deuterosome(GO:0098536) |
0.0 | 0.5 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.4 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.0 | 1.8 | GO:0043025 | neuronal cell body(GO:0043025) |
0.0 | 0.1 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.0 | 0.1 | GO:0061617 | MICOS complex(GO:0061617) |
0.0 | 0.1 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.0 | 0.0 | GO:0031523 | Myb complex(GO:0031523) |
0.0 | 0.1 | GO:0030427 | site of polarized growth(GO:0030427) |
0.0 | 0.2 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 1.0 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.0 | 0.9 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.1 | GO:0002177 | manchette(GO:0002177) |
0.0 | 0.0 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.0 | 0.0 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.0 | 0.2 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.0 | 0.1 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 0.9 | GO:0097458 | neuron part(GO:0097458) |
0.0 | 0.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.0 | 0.1 | GO:0030286 | dynein complex(GO:0030286) |
0.0 | 0.0 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.0 | 0.0 | GO:0031931 | TORC1 complex(GO:0031931) TOR complex(GO:0038201) |
0.0 | 0.0 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.0 | 0.2 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.0 | 0.0 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.0 | 0.1 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 0.2 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.0 | 0.3 | GO:0005839 | proteasome core complex(GO:0005839) |
0.0 | 0.0 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.0 | 1.2 | GO:0043209 | myelin sheath(GO:0043209) |
0.0 | 0.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.1 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 0.0 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.9 | 17.8 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
3.3 | 16.4 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
2.9 | 5.8 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
2.9 | 8.6 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
2.8 | 17.0 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
2.6 | 7.7 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
2.1 | 14.8 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
2.0 | 10.2 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
2.0 | 6.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.9 | 17.5 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
1.9 | 9.3 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
1.8 | 14.8 | GO:0002162 | dystroglycan binding(GO:0002162) |
1.7 | 8.6 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
1.7 | 8.3 | GO:0004985 | opioid receptor activity(GO:0004985) |
1.6 | 8.0 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
1.5 | 4.4 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
1.4 | 5.6 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
1.4 | 11.1 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
1.3 | 15.2 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
1.2 | 4.8 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
1.2 | 1.2 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
1.2 | 3.5 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
1.1 | 16.9 | GO:0031402 | sodium ion binding(GO:0031402) |
1.1 | 9.0 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
1.1 | 3.4 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
1.1 | 6.6 | GO:0004385 | guanylate kinase activity(GO:0004385) |
1.1 | 7.4 | GO:0003680 | AT DNA binding(GO:0003680) |
1.1 | 11.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
1.1 | 3.2 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
1.0 | 4.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
1.0 | 11.0 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
1.0 | 5.0 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
1.0 | 2.9 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.9 | 2.6 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.8 | 1.6 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.8 | 8.0 | GO:0051378 | serotonin binding(GO:0051378) |
0.8 | 2.3 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.8 | 3.8 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.7 | 14.7 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.7 | 10.2 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.7 | 5.0 | GO:0043495 | protein anchor(GO:0043495) |
0.7 | 3.6 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.7 | 2.9 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.7 | 2.7 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.7 | 2.0 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.7 | 1.3 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.6 | 0.6 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.6 | 1.9 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.6 | 5.1 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.6 | 7.0 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.6 | 1.3 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.6 | 2.5 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.6 | 2.5 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.6 | 1.9 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.6 | 1.9 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.6 | 1.9 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.6 | 10.4 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.6 | 6.0 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.6 | 7.1 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.6 | 3.0 | GO:0048495 | Roundabout binding(GO:0048495) |
0.6 | 2.9 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.6 | 2.9 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.6 | 9.8 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.6 | 1.1 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.6 | 9.5 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.5 | 2.7 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.5 | 2.7 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.5 | 1.1 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.5 | 1.1 | GO:0097016 | L27 domain binding(GO:0097016) |
0.5 | 2.1 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.5 | 3.5 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.5 | 1.5 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.5 | 2.5 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.5 | 2.0 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) dopamine neurotransmitter receptor activity(GO:0004952) |
0.5 | 9.7 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.5 | 2.4 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.5 | 16.7 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.5 | 1.4 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.5 | 7.0 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.5 | 7.8 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.4 | 3.1 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.4 | 11.2 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.4 | 0.4 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.4 | 1.3 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.4 | 1.3 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.4 | 1.3 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.4 | 2.1 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.4 | 3.4 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.4 | 1.3 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.4 | 2.4 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.4 | 9.6 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.4 | 2.4 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.4 | 3.5 | GO:0038191 | neuropilin binding(GO:0038191) |
0.4 | 8.7 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.4 | 7.5 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.4 | 3.4 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.4 | 3.7 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.4 | 2.2 | GO:0030955 | potassium ion binding(GO:0030955) |
0.4 | 1.5 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.4 | 1.1 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.4 | 1.8 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.4 | 0.4 | GO:0015172 | acidic amino acid transmembrane transporter activity(GO:0015172) |
0.4 | 9.0 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.4 | 4.7 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.4 | 1.8 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.4 | 3.2 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.4 | 1.4 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.4 | 1.8 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.3 | 1.0 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.3 | 2.4 | GO:0030957 | Tat protein binding(GO:0030957) |
0.3 | 1.0 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.3 | 5.7 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.3 | 6.0 | GO:0031489 | myosin V binding(GO:0031489) |
0.3 | 1.3 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.3 | 1.0 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.3 | 1.9 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.3 | 1.6 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.3 | 2.5 | GO:0017166 | vinculin binding(GO:0017166) |
0.3 | 6.2 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.3 | 0.6 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.3 | 4.0 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.3 | 1.2 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.3 | 2.4 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.3 | 1.5 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.3 | 0.3 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.3 | 0.9 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.3 | 1.4 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.3 | 3.9 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.3 | 1.4 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.3 | 20.7 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.3 | 1.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.3 | 0.8 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.3 | 1.1 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.3 | 0.5 | GO:0022835 | transmitter-gated ion channel activity(GO:0022824) transmitter-gated channel activity(GO:0022835) |
0.3 | 1.1 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.3 | 1.3 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.3 | 1.1 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.3 | 0.3 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.3 | 0.8 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.3 | 1.3 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.3 | 1.8 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.2 | 0.5 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.2 | 1.7 | GO:0033691 | sialic acid binding(GO:0033691) |
0.2 | 2.4 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 1.7 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.2 | 5.8 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.2 | 1.0 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.2 | 0.2 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) calcium-induced calcium release activity(GO:0048763) |
0.2 | 1.0 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.2 | 1.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.2 | 2.8 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.2 | 6.3 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.2 | 1.9 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.2 | 0.7 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.2 | 1.9 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.2 | 0.2 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.2 | 2.5 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.2 | 0.9 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.2 | 5.4 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.2 | 0.9 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.2 | 2.2 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 0.4 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.2 | 1.3 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.2 | 3.7 | GO:0015026 | coreceptor activity(GO:0015026) |
0.2 | 0.9 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.2 | 2.6 | GO:0031005 | filamin binding(GO:0031005) |
0.2 | 0.7 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.2 | 0.4 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.2 | 0.9 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 0.6 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.2 | 1.3 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.2 | 4.2 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.2 | 1.4 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.2 | 0.6 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.2 | 0.2 | GO:0015556 | succinate transmembrane transporter activity(GO:0015141) C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.2 | 0.4 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.2 | 0.8 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.2 | 0.4 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.2 | 6.8 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.2 | 1.1 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.2 | 0.6 | GO:0016015 | morphogen activity(GO:0016015) |
0.2 | 1.6 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.2 | 4.7 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.2 | 0.4 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.2 | 0.5 | GO:0033265 | choline binding(GO:0033265) |
0.2 | 1.4 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.2 | 0.5 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.2 | 1.1 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.2 | 3.4 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.2 | 0.4 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.2 | 0.9 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 0.3 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.2 | 0.5 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.2 | 2.3 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.2 | 3.3 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.2 | 1.7 | GO:0035198 | miRNA binding(GO:0035198) |
0.2 | 0.7 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.2 | 1.4 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.2 | 0.2 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.2 | 1.4 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.2 | 0.5 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.2 | 1.8 | GO:0016247 | channel regulator activity(GO:0016247) |
0.2 | 2.6 | GO:0043734 | DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.2 | 0.7 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.2 | 1.6 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.2 | 4.0 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.2 | 2.7 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.2 | 0.8 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.2 | 2.4 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.2 | 0.5 | GO:0034862 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.2 | 4.7 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.2 | 0.2 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.2 | 0.3 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.2 | 1.5 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.2 | 2.9 | GO:0030552 | cAMP binding(GO:0030552) |
0.1 | 1.5 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.7 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 0.3 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.1 | 0.9 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 1.0 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.6 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.8 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 0.4 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.1 | 0.6 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.1 | 0.3 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.1 | 0.4 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 0.3 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.1 | 0.7 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.1 | 2.9 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.3 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 1.6 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 1.0 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 0.4 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 1.1 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 0.4 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.1 | 1.8 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 2.1 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.1 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.1 | 0.5 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.4 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 1.4 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 0.2 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.1 | 1.7 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 1.7 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.7 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.1 | 0.3 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.1 | 0.3 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.1 | 1.6 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 0.2 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.1 | 0.4 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.1 | 0.6 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 0.5 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.7 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.2 | GO:0089720 | caspase binding(GO:0089720) |
0.1 | 0.5 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 3.8 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 0.2 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.1 | 0.4 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 0.8 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.2 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.1 | 1.3 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 0.4 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 1.1 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 0.2 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.1 | 1.0 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 0.4 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 0.8 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.1 | 0.3 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.1 | 0.5 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.1 | 0.2 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.1 | 0.9 | GO:0070990 | snRNP binding(GO:0070990) |
0.1 | 0.9 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
0.1 | 0.4 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.1 | 0.2 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 0.8 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.5 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.1 | 0.4 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.1 | 1.8 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.2 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.1 | 0.3 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.1 | 0.1 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.1 | 0.3 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.1 | 9.0 | GO:0003774 | motor activity(GO:0003774) |
0.1 | 0.5 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.1 | 0.1 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.1 | 3.3 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.1 | 0.2 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.1 | 0.8 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 1.8 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.2 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.1 | 0.2 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.1 | 1.5 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 0.6 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 2.1 | GO:0005262 | calcium channel activity(GO:0005262) |
0.1 | 0.1 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.1 | 1.7 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.4 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.1 | 1.8 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 0.1 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.1 | 0.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 0.2 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.1 | GO:0034618 | arginine binding(GO:0034618) |
0.1 | 1.3 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.2 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.1 | 1.2 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 0.2 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 0.4 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.2 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 1.2 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 0.2 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 0.1 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.1 | 0.7 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.1 | GO:0005119 | smoothened binding(GO:0005119) |
0.1 | 0.1 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.1 | 0.3 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.6 | GO:0048038 | quinone binding(GO:0048038) |
0.1 | 1.2 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.1 | 0.5 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.1 | 0.2 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 0.1 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.1 | 1.7 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 0.8 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.1 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.1 | 9.8 | GO:0015631 | tubulin binding(GO:0015631) |
0.1 | 2.6 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.1 | 0.6 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 1.3 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.1 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 0.6 | GO:0034979 | NAD-dependent protein deacetylase activity(GO:0034979) |
0.1 | 0.2 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.1 | 0.2 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 0.9 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 0.3 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.3 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 0.7 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 0.1 | GO:0030519 | snoRNP binding(GO:0030519) |
0.1 | 0.7 | GO:0044654 | dextrin alpha-glucosidase activity(GO:0044653) starch alpha-glucosidase activity(GO:0044654) beta-glucanase activity(GO:0052736) beta-6-sulfate-N-acetylglucosaminidase activity(GO:0052769) glucan endo-1,4-beta-glucosidase activity(GO:0052859) |
0.1 | 0.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 0.2 | GO:0048030 | disaccharide binding(GO:0048030) |
0.1 | 0.4 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.1 | 0.2 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 0.6 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.2 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 0.3 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 0.4 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 0.2 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.1 | 0.2 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.1 | 0.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 0.3 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 0.2 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 0.3 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.1 | 0.6 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.0 | 0.1 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.0 | 0.4 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.2 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.0 | 0.5 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.0 | 0.2 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.2 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.0 | 0.4 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.0 | 0.1 | GO:0033192 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.0 | 0.2 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.8 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.4 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.0 | 0.1 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.0 | 0.1 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.0 | 0.2 | GO:0004083 | bisphosphoglycerate 2-phosphatase activity(GO:0004083) |
0.0 | 0.2 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.0 | 1.2 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.0 | 0.2 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.1 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.0 | 0.5 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 1.4 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.1 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.0 | 0.3 | GO:0055103 | ligase regulator activity(GO:0055103) |
0.0 | 0.2 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.0 | 2.8 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.4 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.0 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.0 | 0.2 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 0.2 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.2 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.0 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.0 | 0.1 | GO:0004337 | geranyltranstransferase activity(GO:0004337) |
0.0 | 0.1 | GO:0035197 | siRNA binding(GO:0035197) |
0.0 | 13.3 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 3.2 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 0.2 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.1 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.0 | 0.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.0 | 0.2 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 0.2 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.0 | 0.0 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.0 | 0.0 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 0.1 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.0 | 1.6 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.3 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 0.8 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.0 | GO:0043398 | HLH domain binding(GO:0043398) |
0.0 | 0.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.2 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 0.0 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.0 | 0.1 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.1 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.0 | 0.1 | GO:0004096 | catalase activity(GO:0004096) |
0.0 | 2.1 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 0.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.1 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 0.4 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.1 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.1 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.0 | 0.1 | GO:0008494 | translation activator activity(GO:0008494) |
0.0 | 0.2 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.1 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.2 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.0 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.0 | 0.0 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.0 | 0.1 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.0 | GO:0004802 | transketolase activity(GO:0004802) |
0.0 | 0.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.0 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.0 | 0.0 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.3 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.3 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.0 | 0.0 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 26.1 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.7 | 0.7 | ST GAQ PATHWAY | G alpha q Pathway |
0.5 | 15.8 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.5 | 11.6 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.5 | 9.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.4 | 11.1 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.4 | 6.3 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.4 | 27.5 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.4 | 4.7 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.3 | 0.3 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.3 | 2.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.3 | 2.4 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.3 | 1.0 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.2 | 3.4 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.2 | 0.2 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.2 | 6.2 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.2 | 2.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.2 | 0.2 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.2 | 2.8 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 2.5 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 8.4 | PID NOTCH PATHWAY | Notch signaling pathway |
0.2 | 7.5 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.2 | 5.6 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.2 | 3.5 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.2 | 0.8 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 1.5 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 0.6 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 0.8 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 0.4 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 1.1 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 1.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 1.0 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 3.6 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 2.4 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 0.4 | ST ADRENERGIC | Adrenergic Pathway |
0.1 | 0.2 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 1.2 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 0.4 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 0.6 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 0.4 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 1.5 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 1.5 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 0.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 0.9 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 1.5 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 1.6 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 2.3 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 0.3 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 0.1 | ST STAT3 PATHWAY | STAT3 Pathway |
0.1 | 0.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 1.7 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 0.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 0.1 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 0.9 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.2 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.0 | 0.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.6 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.6 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.9 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.9 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.8 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.2 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 27.7 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
1.2 | 21.1 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
1.2 | 9.7 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
1.1 | 29.2 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
1.0 | 10.8 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
1.0 | 17.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
1.0 | 3.8 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.9 | 9.8 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.8 | 5.6 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.8 | 11.2 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.8 | 11.8 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.7 | 10.5 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.7 | 16.1 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.7 | 0.7 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.6 | 7.0 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.6 | 1.9 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.6 | 6.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.5 | 2.6 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.5 | 19.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.4 | 0.4 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.4 | 2.9 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.4 | 5.8 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.4 | 5.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.4 | 6.7 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.3 | 4.8 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.3 | 4.7 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.3 | 3.4 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.3 | 8.6 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.3 | 6.4 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.3 | 2.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.3 | 1.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.3 | 4.5 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.3 | 3.1 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.3 | 0.3 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.2 | 4.9 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.2 | 2.7 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.2 | 0.7 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.2 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.2 | 12.0 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.2 | 1.0 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.2 | 1.6 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.2 | 3.6 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.2 | 3.3 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.2 | 3.0 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.2 | 0.3 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.2 | 6.9 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.2 | 0.3 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.2 | 0.3 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.2 | 0.5 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 1.4 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 1.6 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.1 | 3.4 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 0.1 | REACTOME GABA B RECEPTOR ACTIVATION | Genes involved in GABA B receptor activation |
0.1 | 0.2 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 2.3 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 1.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 1.3 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.1 | 2.7 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 1.4 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 0.9 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 3.3 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 4.4 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 1.1 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 0.1 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.1 | 0.6 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.1 | 1.4 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 0.1 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.1 | 1.3 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 1.6 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.1 | 1.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 0.7 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 1.7 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 0.8 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 1.0 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 0.6 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 0.6 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.1 | 0.1 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.1 | 10.9 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 0.5 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 2.2 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 0.1 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.1 | 0.1 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.1 | 1.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 2.7 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 0.6 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 0.1 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.1 | 1.6 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.0 | 1.6 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 0.1 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.0 | 0.0 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.0 | 0.8 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.0 | 0.6 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 2.1 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 1.4 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.1 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.0 | 0.3 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.0 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.4 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.0 | 0.1 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 0.0 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 0.1 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 0.2 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.0 | 0.0 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.0 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.1 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |